Status:
COMPLETED
Effect of Vitamin D Supplementation on Hemoglobin A1c in Patients With Uncontrolled Type 2 Diabetes Mellitus
Lead Sponsor:
ProMedica Health System
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
21-75 years
Phase:
NA
Brief Summary
The purpose of this study is to determine if daily supplementation with 2000 International Units of Vitamin D will improve hemoglobin A1c in uncontrolled type 2 diabetics.
Detailed Description
Vitamin D is typically understood to support musculoskeletal health when administered concomitantly with calcium. A number of recent studies suggest, however, that this important nutrient may play a s...
Eligibility Criteria
Inclusion
- Type 2 diabetes mellitus
- Hemoglobin A1c \>7% measured in the 3 months prior to randomization
- Age 21 to 75 years
Exclusion
- Renal insufficiency (defined as CrCl \<30mL/min)
- Gestational diabetes
- Malabsorption syndrome
- Patients taking vitamin D supplements at doses \>400 international units daily
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2010
Estimated Enrollment :
37 Patients enrolled
Trial Details
Trial ID
NCT00985361
Start Date
October 1 2009
End Date
March 1 2010
Last Update
May 6 2010
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Flower Hospital Family Medicine Residency
Sylvania, Ohio, United States, 43560
2
Center for Health Services
Toledo, Ohio, United States, 43606
3
Toledo Hospital Family Medicine Residency
Toledo, Ohio, United States, 43606